Vivodyne Company
Vivodyne develops lifelike human organs for drug testing and research purposes. The company utilizes robotic systems and artificial intelligence to create realistic human tissues that simulate various organ functions. This innovative approach allows for efficient testing of pharmaceuticals, aiming to replace traditional animal testing methods. By producing over 100,000 human tissues in a short timeframe, Vivodyne enhances the predictive accuracy of drug responses in humans. The organization is committed to improving the preclinical drug testing process, providing valuable insights that can lead to more effective therapies. Through its advanced technology, Vivodyne contributes to the evolution of biomedical research and development.
Founded Date:
2020-01-01
Last Funding Date:
2025-05-29
Industry:
Robotics & Automation
Total Funding:
79999996
Headquarters:
San Francisco
Employee Number:
11-50
Funding Status:
private
Super Industry:
Science, Technology and Engineering
Last Funding Total Value:
40000000
Country:
United States
City:
San Francisco
Founders:
Andrei Georgescu,Dan Huh